Displaying 291 - 300 of 517 News articles. Show 5 | 10 | 20 | 40 | 60 results per page.
Read the latest news from PraxisAuril on the world of Knowledge ExchangeAppleyard Lees open Cambridge Office
10 Feb 2017
Appleyard Lees are delighted to announce the opening of a new office in Cambridge.
BBSRC Innovator of the Year 2017 Competition: Nominations Open
9 Feb 2017
It’s that time of year again when BBSRC looks to recognise and reward researchers (at any stage of their career), who have taken an active part in realising the impact from BBSRC investments and made a difference to the UK economy or society.
Oxford University Innovation’s Isis Enterprise to form as limited company Oxentia
7 Feb 2017
Oxford University Innovation’s management consultancy division to restructure as separate entity.
Cancer Research Technology, UCL, and Tusk Therapeutics join forces to develop cancer immunotherapies
7 Feb 2017
Cancer Research UK's commercial arm, Tusk Therapeutics and UCL announce a new collaborative agreement.
Stevenage Bioscience Catalyst celebrates fifth anniversary
1 Feb 2017
Since 2012, Stevenage Bioscience Catalyst tenants have raised more than £200m.
Midlands universities showcase the “critical mass” of investment opportunity in the region
26 Jan 2017
The University of Birmingham and the University of Nottingham will be presenting jointly at an invitation-only event held by Mercia Technologies PLC, one of the UK’s leading investors in early-stage technology companies, including university spin-out companies.
Graphene Inks spin-out acquired by Versarien
20 Jan 2017
A majority stake in Cambridge Graphene, a spin-out company from the University of Cambridge, has been acquired by UK-based firm Versarien.
Review of the Small Business Research Initiative (SBRI) announced
19 Jan 2017
The Prime Minister announced a Review of the Small Business Research Initiative (SBRI), led by an industry expert with a background in the UK’s science and technology sector.
MRC Technology, Cancer Research UK and Cancer Research Technology collaborate to focus on cancer immunnotherapies
19 Jan 2017
Cancer Research UK, Cancer Research Technology and MRC Technology are joining forces to identify and validate novel drug discovery targets that could lead to new immunotherapy treatments.